Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001354488-12-000259
Filing Date
2012-01-24
Accepted
2012-01-24 06:53:19
Documents
1
Period of Report
2012-01-23

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT issuerdirect_section16.html 4  
1 PRIMARY DOCUMENT issuerdirect_section16.xml 4 2941
  Complete submission text file 0001354488-12-000259.txt   4403
Mailing Address 1004 CHAGFORD WAY RALEIGH NC 27614
Business Address 1004 CHAGFORD WAY RALEIGH NC 27614 919-313-4930
CURAXIS PHARMACEUTICAL Corp (Issuer) CIK: 0001434893 (see all company filings)

EIN.: 261919261 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CURAXIS PHARMACEUTICAL CORPORATION 1004 CHAGFORD WAY RALEIGH NC 27614
Business Address
Novak Terence (Reporting) CIK: 0001524760 (see all company filings)

Type: 4 | Act: 34 | File No.: 333-150937 | Film No.: 12540838